AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucotaj Met 1mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Taj Pharma India Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Glucotaj Met 1mg/1000mg Tablet SR

DiaBetaDuo 1mg/1000mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose control. Administer DiaBetaDuo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including kidney impairment, vision loss, neuropathy, and limb damage. DiaBetaDuo is only one element of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Commonly, DiaBetaDuo may cause hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, lightheadedness, headache, and tremors, and know how to counteract them. Maintain consistent mealtimes and carry readily available glucose sources (e.g., sweets, juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility. Contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic/renal impairment. Disclose any history of heart conditions before commencing treatment. DiaBetaDuo's suitability should be assessed in pregnant or lactating individuals. Regular blood glucose monitoring is crucial, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glucotaj Met 1mg/1000mg Tablet SR

No text was provided to rewrite.

Uses of Glucotaj Met 1mg/1000mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glucotaj Met 1mg/1000mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Glucotaj Met 1mg/1000mg SR tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

Common Side effects of Glucotaj Met 1mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glucotaj Met 1mg/1000mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the Glucotaj Met 1mg/1000mg sustained-release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Glucotaj Met 1mg/1000mg Tablet SR works:

Glucotaj Met SR tablets (1mg glimepiride/1000mg metformin) combine two diabetes medications. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts threefold: it decreases liver glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Glucotaj Met 1mg/1000mg SR tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glucotaj Met 1mg/1000mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glucotaj Met 1mg/1000mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glucotaj Met 1mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glucotaj Met 1mg/1000mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glucotaj Met 1mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate hepatic dysfunction, Glucotaj Met 1mg/1000mg Tablet SR should typically begin at a low dose; however, it's contraindicated in individuals with severe liver disease.

What if you forget to take Glucotaj Met 1mg/1000mg Tablet SR :

Should you forget to take your Glucotaj Met 1mg/1000mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glucotaj Met 1mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glucotaj Met 1mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glucotaj Met 1mg/1000mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glucotaj Met 1mg/1000mg Tablet SR and seek immediate medical attention.
Glucotaj Met 1mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 DM.
Glucotaj Met 1mg/1000mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glucotaj Met 1mg/1000mg SR tablets can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental Vitamin B12 intake is recommended by some researchers.
Glucotaj Met 1mg/1000mg SR tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glucotaj Met 1mg/1000mg SR tablets with alcohol is unsafe. Alcohol can lower your blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glucotaj Met 1mg/1000mg T...
86
MRP 99
13% off